Teladoc Health, Inc. (TDOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 900M 1.8B 2.7B Q4 '14: 43.5M Q1 '15: 50.6M Q2 '15: 58.6M Q3 '15: 67.7M Q4 '15: 77.4M Q1 '16: 87.8M Q2 '16: 96M Q3 '16: 108.4M Q4 '16: 123.2M Q1 '17: 139.2M Q2 '17: 157.3M Q3 '17: 193.5M Q4 '17: 233.3M Q1 '18: 280M Q2 '18: 330M Q3 '18: 372.3M Q4 '18: 417.9M Q1 '19: 456.8M Q2 '19: 492.6M Q3 '19: 519.6M Q4 '19: 553.3M Q1 '20: 605.5M Q2 '20: 716.3M Q3 '20: 867.1M Q4 '20: 1.1B Q1 '21: 1.4B Q2 '21: 1.6B Q3 '21: 1.9B Q4 '21: 2B Q1 '22: 2.1B Q2 '22: 2.2B Q3 '22: 2.3B Q4 '22: 2.4B Q1 '23: 2.5B Q2 '23: 2.5B Q3 '23: 2.6B Q4 '23: 2.6B Q1 '24: 2.6B Q2 '24: 2.6B Q3 '24: 2.6B Q4 '24: 2.6B Q1 '25: 2.6B Q2 '25: 2.5B Q3 '25: 2.5B Q4 '25: 2.5B Q1 '26: 2.5B Q2 '26: 2.5B Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '14: 33.6M Q1 '15: 37.4M Q2 '15: 42.6M Q3 '15: 49.3M Q4 '15: 56.3M Q1 '16: 64.1M Q2 '16: 70.2M Q3 '16: 80M Q4 '16: 91.2M Q1 '17: 103M Q2 '17: 118M Q3 '17: 144.6M Q4 '17: 171.7M Q1 '18: 203.7M Q2 '18: 236M Q3 '18: 260.9M Q4 '18: 289.2M Q1 '19: 310.3M Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19

Operating Income TTM

-15B -10B -5B 0 5B 10B 15B Q4 '14: -15.2M Q1 '15: -25.6M Q2 '15: -38.9M Q3 '15: -47.7M Q4 '15: -55.8M Q1 '16: -57.9M Q2 '16: -56.1M Q3 '16: -63.8M Q4 '16: -62.7M Q1 '17: -62.8M Q2 '17: -62.8M Q3 '17: -64.1M Q4 '17: -75.4M Q1 '18: -79.7M Q2 '18: -83.3M Q3 '18: -77.6M Q4 '18: -70.9M Q1 '19: -74.6M Q2 '19: -78.5M Q3 '19: -82.7M Q4 '19: -80.4M Q1 '20: -78.6M Q2 '20: -63.7M Q3 '20: -63.5M Q4 '20: -506.4M Q1 '21: -570.1M Q2 '21: -641.9M Q3 '21: -682.7M Q4 '21: -265.6M Q1 '22: -6.9B Q2 '22: -9.9B Q3 '22: -9.9B Q4 '22: -13.7B Q1 '23: -7.1B Q2 '23: -4B Q3 '23: -4B Q4 '23: -248.6M Q1 '24: -258.6M Q2 '24: -1B Q3 '24: -1B Q4 '24: -1B Q1 '25: -1.1B Q2 '25: -267.6M Q3 '25: -275.2M Q4 '25: -263M Q1 '26: -204.1M Q2 '26: -186.8M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income TTM

-15B -10B -5B 0 5B 10B 15B Q4 '14: -17M Q1 '15: -27.4M Q2 '15: -41.3M Q3 '15: -50M Q4 '15: -58M Q1 '16: -60.6M Q2 '16: -58.4M Q3 '16: -75M Q4 '16: -74.2M Q1 '17: -74.6M Q2 '17: -75.1M Q3 '17: -76.7M Q4 '17: -106.8M Q1 '18: -115M Q2 '18: -124.7M Q3 '18: -116.6M Q4 '18: -97.1M Q1 '19: -103.4M Q2 '19: -107.6M Q3 '19: -104.7M Q4 '19: -98.9M Q1 '20: -98.3M Q2 '20: -94.7M Q3 '20: -110.2M Q4 '20: -485.1M Q1 '21: -655.2M Q2 '21: -763.3M Q3 '21: -811.8M Q4 '21: -428.8M Q1 '22: -6.9B Q2 '22: -9.9B Q3 '22: -9.9B Q4 '22: -13.7B Q1 '23: -7.1B Q2 '23: -4B Q3 '23: -4B Q4 '23: -220.4M Q1 '24: -233M Q2 '24: -1B Q3 '24: -981.7M Q4 '24: -1B Q1 '25: -1B Q2 '25: -207.4M Q3 '25: -223.6M Q4 '25: -200.3M Q1 '26: -171.1M Q2 '26: -177.4M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue TTM

0 300M 600M 900M Q4 '14: 9.9M Q1 '15: 13.2M Q2 '15: 16M Q3 '15: 18.3M Q4 '15: 21M Q1 '16: 23.7M Q2 '16: 25.8M Q3 '16: 28.4M Q4 '16: 32M Q1 '17: 36.2M Q2 '17: 39.3M Q3 '17: 48.9M Q4 '17: 61.6M Q1 '18: 76.3M Q2 '18: 94M Q3 '18: 111.4M Q4 '18: 128.7M Q1 '19: 146.6M Q2 '19: 160.5M Q3 '19: 169.1M Q4 '19: 184.5M Q1 '20: 212.2M Q2 '20: 261.3M Q3 '20: 323.2M Q4 '20: 390.8M Q1 '21: 464.4M Q2 '21: 533.9M Q3 '21: 598.2M Q4 '21: 650.3M Q1 '22: 691.3M Q2 '22: 713.5M Q3 '22: 730.1M Q4 '22: 744M Q1 '23: 747.1M Q2 '23: 755.1M Q3 '23: 755.5M Q4 '23: 760M Q1 '24: 764.5M Q2 '24: 762M Q3 '24: 755.8M Q4 '24: 751.3M Q1 '25: 753.6M Q2 '25: 756M Q3 '25: 763.5M Q4 '25: 771.6M Q1 '26: 772.3M Q2 '26: 772.6M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Cash Flow TTM

-150M 0 150M 300M 450M Q2 '15: -23.9M Q3 '15: -38.7M Q4 '15: -47.2M Q1 '16: -54M Q2 '16: -58.5M Q3 '16: -57.1M Q4 '16: -51.8M Q1 '17: -47.1M Q2 '17: -38.4M Q3 '17: -34.7M Q4 '17: -34.4M Q1 '18: -35.8M Q2 '18: -36.5M Q3 '18: -14.6M Q4 '18: -4.9M Q1 '19: 1.1M Q2 '19: 10.9M Q3 '19: 14.2M Q4 '19: 29.9M Q1 '20: 31.4M Q2 '20: 60.8M Q3 '20: 79.5M Q4 '20: -53.5M Q1 '21: -65.2M Q2 '21: -48.5M Q3 '21: -4.2M Q4 '21: 194M Q1 '22: 180.3M Q2 '22: 220.5M Q3 '22: 207M Q4 '22: 189.3M Q1 '23: 234.2M Q2 '23: 242.9M Q3 '23: 285.5M Q4 '23: 350M Q1 '24: 345.8M Q2 '24: 333.3M Q3 '24: 337.9M Q4 '24: 293.7M Q1 '25: 300.7M Q2 '25: 303.4M Q3 '25: 292.5M Q4 '25: 294.4M Q1 '26: 288M Q2 '26: 261.2M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow TTM

-150M 0 150M 300M 450M Q2 '15: -27.8M Q3 '15: -44.5M Q4 '15: -53.5M Q1 '16: -60.2M Q2 '16: -62M Q3 '16: -59M Q4 '16: -53.9M Q1 '17: -49.6M Q2 '17: -41M Q3 '17: -37.7M Q4 '17: -37.1M Q1 '18: -38.4M Q2 '18: -39.9M Q3 '18: -17.9M Q4 '18: -8.9M Q1 '19: -2.9M Q2 '19: 7.7M Q3 '19: 10.1M Q4 '19: 26.4M Q1 '20: 27.5M Q2 '20: 56.9M Q3 '20: 76M Q4 '20: -57.5M Q1 '21: -70.4M Q2 '21: -55.3M Q3 '21: -10.9M Q4 '21: 185.5M Q1 '22: 169.9M Q2 '22: 209.9M Q3 '22: 193.7M Q4 '22: 172.8M Q1 '23: 219.3M Q2 '23: 228.6M Q3 '23: 269.2M Q4 '23: 338.6M Q1 '24: 335.5M Q2 '24: 323M Q3 '24: 331.8M Q4 '24: 282.9M Q1 '25: 288.3M Q2 '25: 291.7M Q3 '25: 280.1M Q4 '25: 285.5M Q1 '26: 280.1M Q2 '26: 253.7M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '21: 152.2M Q2 '21: 156.1M Q3 '21: 159.4M Q1 '22: 160.5M Q2 '22: 161.4M Q3 '22: 161.7M Q1 '23: 162.9M Q2 '23: 164.2M Q3 '23: 165.1M Q1 '24: 167.7M Q2 '24: 170.2M Q3 '24: 171.5M Q1 '25: 174.2M Q2 '25: 175.9M Q3 '25: 176.9M Q1 '26: 179.1M Q2 '26: 181M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q4 '14: -10.25 Q1 '15: -13.74 Q2 '15: -18.79 Q3 '15: -16.48 Q4 '15: -2.91 Q1 '16: 2.56 Q2 '16: 9.38 Q3 '16: 9.10 Q4 '16: -1.74 Q1 '17: -1.64 Q2 '17: -1.54 Q3 '17: -1.44 Q4 '17: -1.89 Q1 '18: -1.98 Q2 '18: -2.10 Q3 '18: -1.89 Q4 '18: -1.48 Q1 '19: -1.52 Q2 '19: -1.53 Q3 '19: -1.47 Q4 '19: -1.38 Q1 '20: -1.35 Q2 '20: -1.28 Q3 '20: -1.43 Q4 '20: -5.36 Q1 '21: -6.27 Q2 '21: -6.79 Q3 '21: -6.89 Q4 '21: -2.75 Q1 '22: -43.02 Q2 '22: -61.38 Q3 '22: -61.30 Q4 '22: -84.76 Q1 '23: -43.60 Q2 '23: -24.78 Q3 '23: -24.68 Q4 '23: -1.34 Q1 '24: -1.41 Q2 '24: -5.93 Q3 '24: -5.77 Q4 '24: -5.86 Q1 '25: -5.90 Q2 '25: -1.17 Q3 '25: -1.26 Q4 '25: -1.14 Q1 '26: -0.97 Q2 '26: -0.99 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.